ACTIVE

UREEL PHARMACIE

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result1,3 k €+1 263,2 %over 1 year
Gross margin72,6 k €-56,4 %over 1 year
Equity338,4 k €+0,4 %over 1 year

Identity

Source · BCE/KBO

UREEL PHARMACIE is a Private company with limited liability incorporated in 2009. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Couvin.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0810.842.202
Incorporation
01/04/2009
Legal form
Private company with limited liability
Registered office
Rue de la Ville 6
5660 Couvin · WallonieSee on map
Contributed capital
277 600,00 €
Latest accounts
30/06/2025
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 16 filings

Trend over 16 financial years

20252024202320222021
Income statement
Gross margin72,6 k €166,7 k €183,3 k €173,6 k €253,2 k €
EBITDA5 k €6,1 k €6,9 k €9,6 k €3,6 k €
Operating result4,2 k €3,1 k €3,1 k €6,3 k €1,1 k €
Net result1,3 k €94,6 €384,3 €3,1 k €1,6 k €
Balance sheet
Equity338,4 k €337,1 k €337 k €336,7 k €333,5 k €
Total assets407 k €559,1 k €572,3 k €667,5 k €507,1 k €
Cash45,2 k €162,7 k €258,5 k €265 k €155,9 k €
Debts68,6 k €222 k €235,3 k €330,9 k €173,6 k €
Other
Workforce–4,0 ETP4,5 ETP4,4 ETP4,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 7 ended

Active mandates

Unipharma

Director · since 05 janvier 2021 · 0406.125.637

Represented by LAURENT STAQUET

Active

Ended mandates

BERNADETTE UREEL

Mandate

Ended
BERNADETTE UREEL

Director

Ended
BERNADETTE UREEL

Manager

Ended
CLAUDE LIEVIN

Mandate

Ended

Other companies at this address

Rue de la Ville 6 5660 Couvin
CompanyCBE no.
Unipharma● Active
0406.125.637

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date17/02/202618/02/202509/02/202406/02/202308/02/202223/12/2020
General meeting31/12/202527/01/202525/01/202409/01/202326/01/202221/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202531/12/202517/02/2026FrenchPDF
Abridged model30/06/202427/01/202518/02/2025FrenchPDF
Abridged model30/06/202325/01/202409/02/2024FrenchPDF
Abridged model30/06/202209/01/202306/02/2023FrenchPDF
Abridged model30/06/202126/01/202208/02/2022FrenchPDF
Abridged model30/06/202021/12/202023/12/2020FrenchPDF
Abridged model30/06/201930/12/201919/02/2020FrenchPDF
Abridged model30/06/201831/12/201826/02/2019FrenchPDF
Abridged model30/06/201730/12/201723/02/2018FrenchPDF
Abridged model30/06/201624/01/201724/02/2017FrenchPDF
Abridged model30/06/201515/03/201629/03/2016FrenchPDF
Abridged model30/06/201406/02/201524/02/2015FrenchPDF
Abridged model30/06/201330/12/201314/02/2014FrenchPDF
Abridged model30/06/201230/12/201220/02/2013FrenchPDF
Abridged model30/06/201108/02/201220/02/2012FrenchPDF
Abridged model30/06/201010/03/201122/03/2011FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 7 ended

Active mandates

Unipharma

Director · since 05 janvier 2021 · 0406.125.637

Represented by LAURENT STAQUET

Active

Ended mandates

BERNADETTE UREEL

Mandate

Ended
BERNADETTE UREEL

Director

Ended
BERNADETTE UREEL

Manager

Ended
CLAUDE LIEVIN

Mandate

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates22/02/2021
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares24/07/2014
    CAPITAL, ACTIONS - ASSEMBLEE GENERALE
    PDF
  • Other03/04/2009
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20251,3 k €↑
  2. 2024
    Annual accounts 202494,6 €↓
  3. 2023
    Annual accounts 2023384,3 €↓
  4. 2022
    Annual accounts 20223,1 k €↑
  5. 2021
    Annual accounts 20211,6 k €↓
  6. 2020
    Annual accounts 2020203,6 k €↑
  7. 2019
    Annual accounts 201970,7 k €↑
  8. 2018
    Annual accounts 201849,9 k €↑
  9. 2017
    Annual accounts 2017-230,9 k €↓
  10. 2016
    Annual accounts 201615,8 k €↓
  11. 2015
    Annual accounts 201518,5 k €↓
  12. 2014
    Annual accounts 201461,8 k €↓
  13. 2013
    Annual accounts 201393 k €↓
  14. 2012
    Annual accounts 2012127,5 k €↑
  15. 2011
    Annual accounts 201184,1 k €↓
  16. 2010
    Annual accounts 201091,9 k €
  17. 01/04/2009
    IncorporationPrivate company with limited liability